EuroPCR 2024 - We are joined by Dr Bernardo Cortese (Ospedale Fate bene Fratelli, IT) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on structural heart disease care.

Trials covered in detail include:

• LANDMARK
• ABILITY
• CAGEFREE II
• PICCOLETO VI

Recorded remotely onsite at EuroPCR 2024, Paris by William Cadden